This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 544824
Submitted by lobbyist on: March 29, 2016 12:41:45 PM
Accepted by Registrar on: April 4, 2016 12:02:30 PM
Designated Filer Information
| Landau, Dr. Craig |
| 575 Granite Court | |
|
Pickering, ON, L1W 3W8
|
905-420-6400 |
| Canada |
Organization Information
| Purdue Pharma Inc |
| Purdue Pharma is a research-based pharmaceutical company in Pickering, Ontario. Purdue Pharma (Canada) (www.purdue.ca) is committed to improving patient health and well-being by developing innovative medicines and supporting quality education for the safe use of its products. Purdue is a recognized leader in research and development of products for the treatment of pain. Its portfolio of products also includes medication for the treatment of attention deficit hyperactivity disorder (ADHD), respiratory disease, gastrointestinal disorders and infection control. |
| 575 Granite Court | |
|
Pickering, ON, L1W 3W8
|
905-420-6400 |
| Canada |
Relevant Affiliates
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
| March 29, 2016 | |
| September 25, 2016 |
Organization's In-House Lobbyists
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Discuss responsible prescribing of medication, in particular prescription opioids and ADHD medication, including the value of Abuse Deterrent Formulations as a means of ensuring appropriate and responsible access to and use of such medicines. Additionally, preparation for the introduction of new generations of existing medications.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Staff of Minister | Minister of Health | March 29, 2016 | |
| Public Agency | Health | March 29, 2016 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Discuss responsible prescribing of medication, in particular prescription opioids and ADHD medication, including the value of Abuse Deterrent Formulations as a means of ensuring appropriate and responsible access to and use of such medicines. Additionally, preparation for the introduction of new generations of existing medications.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Staff of Minister | Minister of Health | March 29, 2016 | |
| Minister | Lake, Terry | Minister of Health | March 29, 2016 |
| Public Agency | Health | March 29, 2016 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Discuss responsible prescribing of medication, in particular prescription opioids and ADHD medication, including the value of Abuse Deterrent Formulations as a means of ensuring appropriate and responsible access to and use of such medicines. Additionally, preparation for the introduction of new generations of existing medications.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Staff of Minister | Minister of Health | March 29, 2016 | |
| Public Agency | Health | March 29, 2016 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Discuss responsible prescribing of medication, in particular prescription opioids and ADHD medication, including the value of Abuse Deterrent Formulations as a means of ensuring appropriate and responsible access to and use of such medicines. Additionally, preparation for the introduction of new generations of existing medications.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Staff of Minister | Minister of Health | March 29, 2016 | |
| Public Agency | Health | March 29, 2016 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Discuss responsible prescribing of medication, in particular prescription opioids and ADHD medication, including the value of Abuse Deterrent Formulations as a means of ensuring appropriate and responsible access to and use of such medicines. Additionally, preparation for the introduction of new generations of existing medications.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Staff of Minister | Minister of Health | March 29, 2016 | |
| Public Agency | Health | March 29, 2016 |